New diagnosis of multiple sclerosis in the setting of mRNA COVID-19 vaccine exposure
Karlo Toljan, Moein Amin, Amy Kunchok, Daniel Ontaneda
Topics & Concepts
Multiple sclerosisMedicineVaccinationCoronavirus disease 2019 (COVID-19)ImmunologyDemyelinating diseasePlasmapheresisSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)DiseaseInternal medicineInfectious disease (medical specialty)AntibodyMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersSARS-CoV-2 and COVID-19 Research